This is a request for an ADAMHA SDA grant. The overall goal of this project is to elucidate the molecular mechanism of the cellular trafficking of human muscarinic cholinergic receptor, Hm 1. Deficits in the cholinergic system in the central nervous system may contribute to memory impairments associated with neurodegenerative disorders such as Alzheimers disease, and cholinergic therapy has shown some limited success in treating these disorders. For the success of any long-term therapy, receptor regulation is an essential factor involving desensitization and downregulation. The molecular and cellular mechanisms of downregulation remain unknown at present for any G protein coupled receptor. This project focuses on the processes of internalization, sequestration, recycling, and downregulation of Hm 1. The initial goal is to identify the receptor domains involved in controlling these processes in Hm 1 receptor, and preliminary results suggest that more than one region of the receptor may be involved in the process of internalization. The novel hypothesis will be tested that receptor domains exist that inhibit, rather than mediate, receptor internalization. If correct, such domains could account for the persistence of many G protein coupled receptors at the cell surface even after agonist-activation, and for receptor sequestration without internalization. The second part of the project will involve studying the cellular mechanisms of receptor internalization. The role of phosphorylation in receptor sequestration, internalization, recycling and downregulation will be elucidated with the use of point mutations at serine and threonine residues in the third cytoplasmic loop and carboxy tail of the receptor. The cellular pathway, clathrin coated pits or noncoated vesicles, involved in internalization of the Hm 1 receptor will be determined. In addition the major proteins mediating these cellular processes will be identified. Finally the functional state of the internalized Hm 1 receptor, with respect to maintaining its coupling to a specific G protein, will be revealed. These combined results are expected to enhance significantly the current understanding of the regulation of a prototype G protein coupled receptor. This enhanced knowledge can be further extrapolated to other G protein coupled receptors which include many neurotransmitter and hormonal receptors.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Scientist Development Award (K21)
Project #
5K21MH000996-02
Application #
3089084
Study Section
Research Scientist Development Review Committee (MHK)
Project Start
1992-05-01
Project End
1997-04-30
Budget Start
1993-05-01
Budget End
1994-04-30
Support Year
2
Fiscal Year
1993
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Type
Schools of Pharmacy
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Shockley, M S; Tolbert, L M; Tobin, A B et al. (1999) Differential regulation of muscarinic M1 and M3 receptors by a putative phosphorylation domain. Eur J Pharmacol 377:137-46
Ito, K; Haga, T; Lameh, J et al. (1999) Sequestration of dopamine D2 receptors depends on coexpression of G-protein-coupled receptor kinases 2 or 5. Eur J Biochem 260:112-9
Tolbert, L M; Lameh, J (1998) Antibody to epitope tag induces internalization of human muscarinic subtype 1 receptor. J Neurochem 70:113-9
Tsuga, H; Kameyama, K; Haga, T et al. (1998) Internalization and down-regulation of human muscarinic acetylcholine receptor m2 subtypes. Role of third intracellular m2 loop and G protein-coupled receptor kinase 2. J Biol Chem 273:5323-30
Segredo, V; Burford, N T; Lameh, J et al. (1997) A constitutively internalizing and recycling mutant of the mu-opioid receptor. J Neurochem 68:2395-404
Shockley, M S; Burford, N T; Sadee, W et al. (1997) Residues specifically involved in down-regulation but not internalization of the m1 muscarinic acetylcholine receptor. J Neurochem 68:601-9
Arden, J; Lameh, J (1996) Agonist-induced internalization of human ml muscarinic receptor mutants: immunofluorescence confocal microscopy. Proc West Pharmacol Soc 39:51-4
Tolbert, L M; Lameh, J (1996) Human muscarinic cholinergic receptor Hm1 internalizes via clathrin-coated vesicles. J Biol Chem 271:17335-42
Arden, J R; Segredo, V; Wang, Z et al. (1995) Phosphorylation and agonist-specific intracellular trafficking of an epitope-tagged mu-opioid receptor expressed in HEK 293 cells. J Neurochem 65:1636-45
Hogger, P; Shockley, M S; Lameh, J et al. (1995) Activating and inactivating mutations in N- and C-terminal i3 loop junctions of muscarinic acetylcholine Hm1 receptors. J Biol Chem 270:7405-10

Showing the most recent 10 out of 13 publications